DPP4 and type 2 diabetes mellitus: found that treatment with DPP‐4 inhibitor for 6 months significantly improved the cognitive ability and increased the Aβ1‐42/Aβ1‐40 value in elderly patients with type 2 diabetes mellitus combined with post‐stroke mild cognitive impairment.